Resokine (aTyr Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameResokine (aTyr Pharma)

Drug Alias NameTruncated-tRNA synthetase - aTyr PharmaResected-tRNA synthetase - aTyr PharmaHistidyl-tRNA synthetase - aTyr PharmaHisRSN4 - aTyr PharmaHRS (1-60) - aTyr Pharma +[7]

ClassificationBiologics

Mechanisms of ActionHistidyl-tRNA synthetase modulators

TargetsHistidyl-tRNA synthetase

Therapy Area/IndicationsImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAtyr Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAtyr Pharma

Active IndicationsN/A

Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A